花王股份(603007.SH):實控人涉嫌內幕交易遭證監會立案調查
格隆匯2月25日丨花王股份(603007.SH)宣佈,公司實際控制人肖國強於2021年2月23日晚間收到中國證監會的《調查通知書》(編號:渝證調查字2021005號),主要內容為因其涉嫌內幕交易,根據《中華人民共和國證券法》的有關規定,中國證監會決定對其立案調查。
肖國強未直接持有公司股份,其通過花王集團間接持有公司股份,不屬於公司控股股東、持股5%以上股東。該次立案調查不會導致公司控股股東花王集團因進行股份協議轉讓而違反相關法律、法規的規定。
該次調查事項系對肖國強個人的調查,其未在公司擔任任何職務,不會對公司日常生產經營產生不利影響,公司經營管理、業務及財務狀況正常。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.